Αναζήτηση
ΚΛΕΙΣΙΜΟΣυζυγιακά Πολυμερή
Δρ. Χρήστος Χώχος
The strategic plan of the Laboratory of Conjugated Polymers for Healthcare, Bioelectronics and Bioimaging is the study of conjugated polymers optoelectronic properties for cancer bioimaging, cancer therapy and bioelectronic application in order to enhance existing processes and produce innovate new products. The activities of the Laboratory are focusing on the interplay between the science of conjugated polymers and their biological function towards cancer theranostic and bioelectronic applications.

Main Research Directions / Ongoing Research Activities
Cancer represents a serious public health concern and, for centuries, has been a leading cause of death around the globe. To improve the clinical outcome and survival rate of cancer patients, regular screening, surveillance programs, and early intervention are widely recognized as the best methods used in cancer diagnosis and therapy. Conventional tumor therapies such as chemotherapy, radiotherapy, and surgery have proved successful, but also cause a variety of serious side effects to cancer patients during treatment. To improve treatment efficacy and reduce side effects, further efforts are now devoted to better identify different cancer therapeutic options that are effective, affordable, and acceptable to patients. Meanwhile, the development of non-invasive imaging technologies and image-guided tumor therapies is indispensable to improve the survival rate of cancer patients.
The development of nanoscaled theranostic agents that integrate diagnosis and therapy for effective personalized precision medicine has obtained tremendous attention in the past several decades. By virtue of their real-time diagnostic capability, theranostic platforms can identify the location of a tumor, detect the accumulation of theranostic agents, and monitor the therapeutic response as well as destroy tumors with higher specificity and sensitivity.
To date, conjugated polymers as organic π-conjugated macromolecules have been explored as optically and electronically active materials for versatile optoelectronic devices and as nanoprobes for various biomedical applications. Specifically, as a novel category of photonic nanomaterials, π-conjugated polymer nanoparticles, also known as semiconducting polymer nanoparticles (SPNs) have attracted great interest as fluorescent probes for cell tracking, tumor imaging, ultrafast hemodynamic imaging, and chemiluminescence imaging of drug-induced injury and neuroinflammation. This series of applications is most notably due to the excellent properties of high absorption, control dimensions, and good biocompatibility. More importantly, π-conjugated polymer nanoparticles exhibit a high photothermal conversion efficiency, responsible for converting light energy to thermal energy and heat deposition in tumors, ultimately allowing for PTT. Meanwhile, π-conjugated polymer nanoparticles exhibit an extraordinary ability to convert light energy into acoustics. Therefore, they may also serve as a flexible nanoplatforms for in vivo PA of tumors by responsive to reactive oxygen species (ROS), enzyme, and pH.

- “Rational Design of New Aqueous Conjugated Polymer Nanoparticles as Theranostic Agents of Breast Cancer”
Koralli, P.; Tsikalakis, S.; Goulielmaki, M.; Arelaki, S.; Muller, J.; Nega, A. D.; Schiza, A.; Herbst, F.; Gregoriou, V. G.; Dimitrakopoulou-Strauss, A.; Wiemann, S.; Chochos, C. L.* Mater. Chem. Front. 2021, 5, 4950-4962. (Impact Factor 2020: 6.482) - “New Conjugated Polymer Nanoparticles with High Photoluminescence Quantum Yields for Far-red and Near Infrared Fluorescence Bioimaging”
Koralli, P.; Nega, A. D.; Vagiaki, L. E.; Pavlou, A.; Siskos, M. G.; Dimitrakopoulou-Strauss, A.; Gregoriou, V. G.; Chochos, C. L.* Mater. Chem. Front. 2020, 4, 2357 – 2369. (Impact Factor 2020: 6.482)
Development of conjugated polymers for the fabrication of efficient organic photodetectors (OPDs) and their applicability in the detection of weak fluorescent biological signals involved in studies of cellular activity function
This is achieved by manifested the OPDs sensitivity and temporal resolution in the measurement of calcium signals from chemical fluorophores (Fluo-4) and genetically encoded calcium indicators (GECI) associated to changes in intracellular calcium concentration in physiological and pathophysiological conditions in-vitro and ex-vivo for the first time.

Infrared Organic Photodetectors employing Ultralow Bandgap Polymer for Biometric Monitoring
Recent efforts in the field of organic photodetectors (OPD) have been focused on extending broadband detection into the near-infrared (NIR) region. Here, we compare two blends of an ultra-narrow bandgap push-pull polymer TQ-T with state-of-the-art non-fullerene acceptors, IEICO-4F and Y6, to obtain OPDs for sensing in the NIR beyond 1100 nm, which is the cut off for benchmark Si photodiodes. We observed that TQ-T:IEICO-4F device has a superior IR responsivity (0.03 AW-1 at 1200 nm and -2V bias) and can detect infrared light up to 1800 nm, while TQ-T:Y6 blend showed lower responsivity of 0.01 AW-1. The lower dark current in reverse bias obtained in TQ-T:IEICO-4F lead to D* of 109-1010 Jones in the UV-VIS-NIR range, while TQ-T:Y6 shows D* of 107-108 Jones. In-depth photophysics and the morphology analyses links the advanced performance of TQ-T:IEICO-4F to the faster charge separation and a favourable homogenous mixing of the donor-acceptor phases. We demonstrate an application of these devices as biometric sensors in real time heart rate monitoring via photoplethysmography, utilising infrared light.

- “Infrared Organic Photodetectors Employing Ultralow Bandgap Polymer and Non-fullerene Acceptors for Biometric Monitoring”
Jacoutot, P.; Scaccabarozzi, A. D.; Zhang, T.; Qiao, Z.; Aniés, F.; Neophytou, M.; Bristow, H.; Kumar, R.; Moser, M.; Nega, A.; Dimitrakopoulou-Strauss, A.; Gregoriou, V. G.; Anthopoulos, T. D.; Heeney, M.; McCulloch, I.; Bakulin, A. A.; Chochos, C. L.; Gasparini, N. Small 2022, 18, 2200580. (Impact Factor 2020: 13.281). - “Monitoring Fluorescent Calcium Signals in Neural Cells with Organic Photodetectors”
Rezaei-Mazinani, S.; Ivanov, A. I.; Biele, M.; Chochos, C. L.; Rutz, A.; Gregoriou, V. G.; Avgeropoulos, A.; Tedde, S. F.; Bernard, C.; O’Connor, R.; Malliaras, G. G.; Ismailova, E. J. Mater. Chem. C 2019, 7, 9049-9056. (Impact Factor 2020: 7.393).
- Dr. Vasilis Gregoriou (President of NHRF and Director of Research)
- Prof. Dr. Antonia Dimitrakopoulou-Strauss (Clinical Cooperation Unit Nuclear Medicine German Cancer Research Center (DKFZ))
- Prof. Dr. Stefan Wiemann (Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ))
- Prof Apostolos Avgeropoulos (Materials Science Department, University of Ioannina, Greece)
- Dr. Nicola Gasparini (Department of Chemistry and Centre for Processable Electronics, Imperial College London)
- “Development of efficient third generation PV materials and devices to enhance the competitiveness of enterprises to the green energy production (3GPV-4INDUSTRY)” Call: Flagship actions in interdisciplinary scientific areas with special interest for the connection to the productive fabric, Greece 2.0 – National Recovery and Resilience Plan, GSRI. At National Hellenic Research Foundation (NHRF); Project Number: TAEDR 0537347; PI: Christos Chochos 205.000 EUR
- “Incorporating Conjugated Polymers and Non Fullerene Materials of Long Exciton Lifetimes and Low Synthetic Complexity Into Printable Indoor Organic Photovoltaics From Sustainable Solvents (iPHOS)” Call: Hellenic Foundation for Research and Innovation (H.F.R.I.), Sub-action 2 “Funding Projects in Leading Edge Sectors”, Basic Research Financing (Horizontal support for all Sciences), National Recovery and Resilience Plan (Greece 2.0); At National Hellenic Research Foundation (NHRF); Project Number: 017007; PI: Christos Chochos 400.000 EUR
- 2021 HFRI 2nd Call for H.F.R.I.’s Research Projects to Support Faculty Members & Researchers Physical Science Category I PI: Christos Chochos 200.000 EUR.
- 2021 Participation to the NHRF proposal preparation that will be funded by the RRF with €30.700.000 for the establishment of a Center of Excellence which will focus on Theranostics and bioelectronic applications.
- 2021 EU4H-2021-JA-04 Direct grants to Member states’ authorities: network of Comprehensive Cancer Centers: Establishment of new EU Network of Expertise on Cancers and Cancer Conditions (AWP Ref.: DP/C-g-10.1.3)- Budget: 4 000 000 EUR.
- 2021 Award winner of the year for best inventions in Greece from the Hellenic Industrial Property Organisation (OBI).
- 2020 Scholarship proposal granted in the framework of “Reinforcement of Postdoctoral Researchers” from the State Scholarships Foundation (IKY) of Athens/Greece by Dr Panagiota Koralli.
- Participation to “Strategic Relationship between the DKFZ/NCT Heidelberg and the Athens Comprehensive Cancer Center (ACCC) in Athens, Greece for Individualized Cancer Medicine” Helmholtz Association. Funding: 1.500.000Euros (2017-2019) PI. V. G. Gregoriou (Collaborator C. L. Chochos)
